Part of Weill Cornell Graduate School of Medical Sciences. A convergence of Weill Cornell Medical College and the Sloan-Kettering Institute, we are a premiere school in biomedical research. Read more about our programs of study:
The research activities of the Cornell Pharmacology Program faculty cover broad areas of modern pharmacological sciences. Faculty carry out research in cancer pharmacology, neuropharmacology, cardiovascular pharmacology, drug metabolism, toxicology, proteomics, molecular pharmacology, receptors and signal transduction, and drug design.
POSTDOCTORAL RESEARCH:
PHOTOGRAPHS:
Text size:
Dr. Marcus Reidenberg will speak about informed consent at the WCMC 2nd Annual Research Integrity and Compliance Conference on Nov. 6 and about Drug Interactions in the WCMC Health and Wellness symposium on Nov. 10.
Congratulations to Dr. Geoffrey Abbott and his research team, which included Kerry Purtell, a second year Pharmacology Program graduate student, for their publication in Nature Medicine (2009 Sep 20. [Epub ahead of print]) that linked "genes previously known to be essential to the coordinated, rhythmic electrical activity of cardiac muscle -a healthy heartbeat- to thyroid hormone (TH) biosynthesis! The press release about this publication, which included an interview with Dr. Abbott, can be found at ">http://news.med.cornell.edu/wcmc/wcmc2009/09_20_09.shtml The full paper can be downloaded here.
Congratulations to Dr. Samie R. Jaffrey, a recipient of an NIH 2009 Transformative R01 Award. Project title: "Novel Fluorescent Sensors for Simple, Sensitive, and Specific Protein Detection". This was a very competitive research award - only 42 were awarded throughout the USA. A press release from NIH occured on September 24, 2009. For more information about the project visit http://projectreporter.nih.gov/project_description.cfm?projectnumber=1R01EB010249-01
Congratulations to Dr. Charles E. Inturrisi, a recipient of a two year RC2 award from NIH for a project entitled: “Comparative Effectiveness of Interventions for Chronic Pain Management”. The project will prospectively and retrospectively examine the long-term outcomes of treatments for chronic cancer and non-cancer pain received by patients at the four local hospital-based outpatient Pain Clinics... read more
Congratulations to Dr. Miklos Toth, a recipient of an NIH EUREKA (Exceptional, Unconventional Research Enabling Knowledge Acceleration) Award for his research project entitled: “Non-Genetic Transmission of Genetic Risk: Mechanism and Relevance to Psychiatric Disorders”. For more information about the EUREKA Awards please visit http://www.nih.gov/news/health/sep2008/nigms-03.htm
Tuesday, November 10, 2009, 4:00 pm, Room A-250
Jean-Pierre Altier
Retired as Vice President, Global Pricing and Reimbursement, Pfizer, Inc.
"The Power of Pricing in Product Success: Developing an Efficient Value Proposition"
